A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
The principal excitatory neurotransmitter in the vertebrate central nervous system, L-glutamate, acts on three classes of ionotripic glutamate receptors, named after the agonists AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxalole-4-propionic acid), NMDA (N-methyl-D-aspartate) and kainate. The development of selective pharmacological agents has led to a detailed understanding of the physiological and pathological roles of AMPA and NMDA receptors. In contrast, the lack of selective kainate receptor ligands has greatly hindered progress in understanding the roles of kainate receptors. Here we describe the effects of a potent and selective agonist, ATPA ((RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl)propanoic acid) and a selective antagonist, LY294486 ((3SR, 4aRS, 6SR, 8aRS)-6-((((1H-tetrazol-5-yl) methyl)oxy)methyl)-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylic acid), of the GluR5 subtype of kainate receptor. We have used these agents to show that kainate receptors, comprised of or containing GluR5 subunits, regulate synaptic inhibition in the hippocampus, an action that could contribute to the epileptogenic effects of kainate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In hippocampus, exogenous kainate reduces the amplitude and Pr of evoked IPSCs onto CA1 pyramidal cells (208, 231, 734, 951) (however cf. with Refs. 231, 332).”
From Hippocampal GABAergic Inhibitory Interneurons (2017) · cites this paper as [208]
Citations
Cites
Hollmann, M., & Heinemann, S. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.000335 · Cited by 3,975
Molecular diversity of glutamate receptors and implications for brain function
Nakanishi, S. (1992) · Science · doi:10.1126/science.1329206 · Cited by 2,543
Excitatory Amino Acid Transmitters
Watkins, J. C., & Evans, R. H. (1981) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.001121 · Cited by 2,491 · cited 1×
“gif" NDATA ITEM> ]> The principal excitatory neurotransmitter in the vertebrate central nervous system, L -glutamate, acts on three classes of ionotripic glutamate receptors, named after the agonists AMPA (α-amino-3-hydroxy-5-methyl-4-isoxalole-4-propionic acid), NMDA ( N -methyl- D -aspartate) and kainat”
BackgroundMonaghan, D. T., Bridges, R. J., & Cotman, C. W. (1989) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.29.040189.002053 · Cited by 2,194
Excitatory amino acid receptors in the vertebrate central nervous system.
Collingridge, G. L., & Lester, R. A. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00025-0 · Cited by 1,341
Self-citationBettler, B., Boulter, J., Hermans-Borgmeyer, I., O'Shea-Greenfield, A., Deneris, E. S., Moll, C., Borgmeyer, U., Hollmann, M., & Heinemann, S. (1990) · Neuron · doi:10.1016/0896-6273(90)90213-y · Cited by 649 · cited 1×
“Here we describe the effects of a potent and selective agonist, ATPA (( RS )-2-amino-3-(3-hydroxy-5- tert -butylisoxazol-4-yl)propanoic acid) and a selective antagonist, LY294486 ((3SR, 4aRS, 6SR, 8aRS)-6-((((1H-tetrazol-5-yl) methyl)oxy)methyl)-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylic acid),…”
BackgroundPartin, K. M., Patneau, D. K., Winters, C. A., Mayer, M. L., & Buonanno, A. (1993) · Neuron · doi:10.1016/0896-6273(93)90220-l · Cited by 583
Bettler, B., & Mulle, C. (1995) · Neuropharmacology · doi:10.1016/0028-3908(94)00141-e · Cited by 456
Huettner, J. E. (1990) · Neuron · doi:10.1016/0896-6273(90)90163-a · Cited by 420 · cited 1×
“Currents activated by kainate in acutely isolated dorsal root ganglion (DRG) neurons are thought to be mediated by GluR5 receptor”
BackgroundRegulation of glutamate release by presynaptic kainate receptors in the hippocampus
Chittajallu, R., Vignes, M., Dev, K. K., Barnes, J. M., Collingridge, G. L., & Henley, J. M. (1996) · Nature · doi:10.1038/379078a0 · Cited by 394 · cited 1×
“GYKI53655 (LY300168) was used to eliminate AMPA receptor-mediated synaptic transmission while preserving functional kainate receptor”
MethodSelf-citation
Research works printed but not linked: 2
- Seeburg, P. H. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 14, 297–303 (1993).
- Bleakman, D. et al. Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3 S, 4a R, 6 R, 8a R)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3 carboxylic-acid. Mol. Pharmacol. 49, 581–585 (1996).
Cited by
Items 101–200 of 427
Lauri, S. E., Delany, C. M., Clarke, V. R. J., Bortolotto, Z. A., Ornstein, P. L., Isaac, J. T. R., & Collingridge, G. L. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00152-6 · Cited by 94
Self-citationAroniadou‐Anderjaska, V., Qashu, F. M., & Braga, M. F. M. (2006) · Amino Acids · doi:10.1007/s00726-006-0415-x · Cited by 106
“Subsequently, we observed that a specific GluR5KR agonist, ATPA (Clarke et al., 1997) enhances the frequency and amplitude of action poten- tial-dependent, spontaneous GABAergic currents (IPSCs) recorded from BLA pyramidal cells (Braga et al., 2003).”
The active role of astrocytes in synaptic transmission
Vesce, S., Bezzi, P., & Volterra, A. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050488 · Cited by 101
Functional GluR6 Kainate Receptors in the Striatum: Indirect Downregulation of Synaptic Transmission
Chergui, K., Bouron, A., Normand, E., & Mulle, C. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-02175.2000 · Cited by 91
“In CA1 pyramidal cells of the hippocampus, activation of KARs also depresses evoked GABAergic synaptic transmission (Fisher and Alger, 1984; Clarke et al., 1997; Rodriguez-Moreno et al., 1997; Cossart et al., 1998; Frerking et al., 1998; Bureau et al., 1999).”
BackgroundKerchner, G. A., Wilding, T. J., Huettner, J. E., & Zhuo, M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-18-08010.2002 · Cited by 94
“The larger effect of ATPA versus KA in GluR6/ cultures may reflect activation of a greater proportion of receptors by 2 M ATPA than by 10 M KA, consistent with the 20-fold lower EC50 of ATPA compared with KA at native receptors on DRG neurons (0.6 vs 12 M, respectively) ( Clarke et al., 1997 ).”
ResultInfluentialThe role of mammalian ionotropic receptors in synaptic plasticity: LTP, LTD and epilepsy
Kullmann, D. M., Asztély, F., & Walker, M. C. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000640 · Cited by 109
Ali, A. B., Rossier, J., Staiger, J. F., & Audinat, E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-02992.2001 · Cited by 88
“…specifically in interneurons (Bahn et al., 1994; Cauli et al., 2000), therefore to activate KA receptors on FS cells, bath application of (RS)-S-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) (ATPA), which has been proposed to be a GluR5 subunit-selective agonist (Clarke et al., 1997), was used.”
BackgroundMethodInfluentialAkgül, G., & McBain, C. J. (2016) · The Journal of Physiology · doi:10.1113/jp271764 · Cited by 87
“…(eIPSC) amplitudes and increases failures of eIPSCs onto CA1 pyramidal neurons, as well as decreasing miniature (m)IPSC frequency onto interneurons (Clarke et al. 1997; Rodriguez-Moreno et al. 1997; Bureau et al. 1999; Cossart et al. 2001; Maingret et al. 2005) indicating a role for presynaptic…”
BackgroundKainate receptors with a metabotropic modus operandi
Moreno, A. R., & Sihra, T. S. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.10.001 · Cited by 95
“Presynaptic metabotropic actions of KARs KARs controlling GABA release Rodri´guez-Moreno et al. [10] and Clarke et al. [ 11 ] first described that the activation of KARs by kainate (KA) causes a decrease in GABA release at inhibitory synapses in a variety of hippocampal models (cultures, slices and in vivo )( Figure 1…”
BackgroundKainate receptors in the hippocampus
Carta, M., Fièvre, S., Gorlewicz, A., & Mulle, C. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12590 · Cited by 86
“(Clarke et al., 1997; Rodriguez-Moreno & Lerma, 1998).”
Lerma, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80407-9 · Cited by 84
Fisahn, A. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.077388 · Cited by 82
“Functional KARs are expressed at both presynaptic and postsynaptic sites and their activation has a multitude of effects (Chittajallu et al. 1996; Castillo et al. 1997; Clarke et al. 1997; RodriguezMoreno et al. 1997, 2000; Vignes & Collingridge, 1997; Cossart et al. 1998, 2001; Frerking et al. 1998, 1999; Contractor…”
BackgroundGlutamatergic mechanisms for speed control and network operation in the rodent locomotor CPG
Talpalar (2010) · Frontiers in Neural Circuits · doi:10.3389/fncir.2010.00019 · Cited by 82
“UBP 302 is reported as an antagonist of KARs containing the GluR5 subunit (Clarke et al., 1997; Mayer et al., 2006; Ireland et al., 2008).”
Kidd, F. L., Coumis, U., Collingridge, G. L., Crabtree, J. W., & Isaac, J. T. R. (2002) · Neuron · doi:10.1016/s0896-6273(02)00699-2 · Cited by 91
Self-citationMiu, P., Jarvie, K. R., Radhakrishnan, V., Gates, M. R., Ogden, A.-M., Ornstein, P. L., Zarrinmayeh, H., Ho, K. H., Peters, D., Grabell, J., et al. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00027-2 · Cited by 79
Self-citationSpecialized Inhibitory Synaptic Actions Between Nearby Neocortical Pyramidal Neurons
Ren, M., Yoshimura, Y., Takada, N., Horibe, S., & Komatsu, Y. (2007) · Science · doi:10.1126/science.1135468 · Cited by 79
Rusakov, D. A., Harrison, E., & Stewart, M. G. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00023-9 · Cited by 83
Kainate Receptors: Role in Epilepsy
Falcón‐Moya, R., Sihra, T. S., & Moreno, A. R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00217 · Cited by 89
“Hippocampal KARs containing GluK1 subunits are mostly expressed in interneurons, where the reduction of GABA release results in the increased excitability of glutamatergic principal neurons (Clarke et al., 1997; Rodríguez-Moreno et al., 1997, 2000; Rodríguez-Moreno and Lerma, 1998), or enhance inhibition by increasing…”
BackgroundModulation of fast synaptic transmission by presynaptic ligand-gated cation channels
Khakh, B. S., & Henderson, G. (2000) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(00)00111-9 · Cited by 81
Weiss, B., Alt, A. J., Ogden, A. M. L., Gates, M. R., Dieckman, D. K., Clemens‐Smith, A., Ho, K. H., Jarvie, K. R., Rizkalla, G., Wright, R. A., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101428 · Cited by 76
“Several compounds belonging to this series have no effect at the GLUK6 receptor and varying degrees of selectivity for kainate receptors versus AMPA receptors (Clarke et al., 1997; Savidge et al., 1997; Vignes et al., 1997).”
BackgroundSelf-citationDolman, N. P., More, J. C. A., Alt, A. J., Knauss, J. L., Pentikäinen, O. T., Glasser, C. R., Bleakman, D., Mayer, M., Collingridge, G. L., & Jane, D. E. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061041u · Cited by 83
Self-citationKainate Receptors Exhibit Differential Sensitivities to (S)-5-Iodowillardiine
Swanson, G. T., Green, T., & Heinemann, S. F. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13262-2 · Cited by 74
“mission in the hippocampus (Clarke et al., 1997) relied on the”
InfluentialParadoxical Anti-Epileptic Effects of a GluR5 Agonist of Kainate Receptors
Khalilov, I., Hirsch, J., Cossart, R., & Ben-Ari, Y. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.88.1.523 · Cited by 73
Braga, M. F. M., Aroniadou‐Anderjaska, V., Li, H., & Rogawski, M. A. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.153908 · Cited by 69
“GluK1 kainate receptor-mediated postsynaptic currents were evoked by micropressure application of the selective GluK1 agonist ATPA (10 M; Clarke et al., 1997; Jane et al., 2009), in the presence of D-APV (50 M), GYKI 53655 (50 M), bicuculline (10 M), and SCH 50911 (10 M), to block NMDA, AMPA, GABAA, and GABAB receptor…”
The synaptic activation of the GluR5 subtype of kainate receptor in area CA3 of the rat hippocampus
Vignes, M., Bleakman, D., Lodge, D., & Collingridge, G. L. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00158-5 · Cited by 68
Self-citationCortical Glutamatergic Markers in Schizophrenia
Scarr, E., Beneyto, M., Meador‐Woodruff, J. H., & Dean, B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300758 · Cited by 69
“In addition, it has also been shown that activating receptors incorporating the GluR5 subunit results in a reduction of g-aminobutyric acid (GABA) inhibitory synaptic transmission (Clarke et al, 1997), an effect that is again reversed by the administration of a GluR5-preferring antagonist.”
BackgroundGeneration and Analysis of GluR5(Q636R) Kainate Receptor Mutant Mice
Sailer, A., Swanson, G. T., Pérez-Otaño, I., O’Leary, L., Malkmus, S. A., Dyck, R. H., Dickinson-Anson, H., Schiffer, H. H., Maron, C., Yaksh, T. L., et al. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08757.1999 · Cited by 67
“On the basis of some of these results, it has been suggested that GluR5-containing kainate receptors play a role in either facilitating (Clarke et al., 1997) or inhibiting (Cossart et al.”
BackgroundBrickley, S. G., Farrant, M., Swanson, G. T., & Cull-Candy, S. G. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00135-6 · Cited by 74
GluR5 Kainate Receptors, Seizures, and the Amygdala
ROGAWSKI, M. A., GRYDER, D., CASTANEDA, D., YONEKAWA, W., BANKS, M. K., & LI, H. E. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07079.x · Cited by 65
Excitatory amino acid agonists and antagonists: pharmacology and therapeutic applications
Trist, D. G. (2000) · Pharmaceutica Acta Helvetiae · doi:10.1016/s0031-6865(99)00053-9 · Cited by 72
AMPA Receptor Activates a G-Protein that Suppresses a cGMP-Gated Current
Kawai, F., & Sterling, P. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-08-02954.1999 · Cited by 68
“The cGMP-gated current was observed in approximately half of the cells (37 of 73).”
BackgroundChoi, K. H., Zepp, M. E., Higgs, B. W., Weickert, C. S., & Webster, M. J. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0956 · Cited by 62
Neuroendocrine Regulation of Puberty
Ojeda, S. R., & Terasawa, E. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50077-9 · Cited by 81
Kullmann, D. M., Min, M.-Y., Asztely, F., & Rusakov, D. A. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0392 · Cited by 61
Aroniadou-Anderjaska, V., Pidoplichko, V. I., Figueiredo, T. H., Almeida-Suhett, C. P., Prager, E. M., & Braga, M. F. M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.006 · Cited by 60
“…SCH50911, a GABAB receptor antagonist, (RS)-2amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid (ATPA), a selective GluK1R agonist (Clarke et al., 1997; Jane et al., 2009), and UBP302, a selective GluK1R antagonist, with similar affinity for homomeric and heteromeric GluK1 kainate…”
BackgroundMetabotropic actions of kainate receptors in the CNS
Rodríguez‐Moreno, A., & Sihra, T. S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04924.x · Cited by 60
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents
Sarro, G. D., Ferreri, G., Gareri, P., Russo, E., Sarro, A. D., Gitto, R., & Chimirri, A. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)01040-7 · Cited by 60
“Since previous findings demonstrated that kainate receptors, containing the GluR5 subtype of kainate receptor, regulate synaptic inhibition in the hippocampus and could provide a selective and new target for antiepileptic therapy (Clarke et al., 1997; Löscher et al., 1999), it could be interesting to evaluate the effe…”
ResultPsychotropic and neurotropic activity
Vogel, H. G., & Vogel, W. H. (1997) · Springer eBooks · doi:10.1007/978-3-662-03333-3_5 · Cited by 63
Fritsch, B., Qashu, F., Figueiredo, T. H., Aroniadou-Anderjaska, V., Rogawski, M. A., & Braga, M. F. M. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.06.034 · Cited by 60
Ionotropic glutamate receptors
Bigge, C. F. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80065-9 · Cited by 78
Heterogeneity of homomeric GluR5 kainate receptor desensitization expressed in HEK293 cells
Swanson, G. T., & Heinemann, S. F. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.639ba.x · Cited by 59
“…studies suggest GluR5 subunits contribute to kainate receptors that modulate inhibitory synaptic transmission to CA1 pyramidal neurons (Clarke et al. 1997; Rodriguez-Moreno et al. 1997) and participate in pain transmission in dorsal root ganglion neurons (Agrawal & Evans, 1986;…”
BackgroundO’Neill, M. J., Bogaert, L., Hicks, C. A., Bond, A., Ward, M., Ebinger, G., Ornstein, P. L., Michotte, Y. M., & Lodge, D. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00250-6 · Cited by 63
Self-citationKidd, F. L., & Isaac, J. T. R. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.3.1139 · Cited by 59
Perkinton, M. S., & Sihra, T. S. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00573-9 · Cited by 66
Procter, M., Houghton, A. K., Faber, E. S. L., Chizh, B. A., Ornstein, P. L., Lodge, D., & Headley, P. M. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00136-1 · Cited by 58
Self-citationResolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA
Stensbøl, T. B., Borre, L., Johansen, T. N., Egebjerg, J., Madsen, U., Ebert, B., & Krogsgaard‐Larsen, P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00512-9 · Cited by 57
Rogawski, M. A., Kurzman, P. S., Yamaguchi, S.-I., & Li, H. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00112-x · Cited by 56
“, 1995), and the availability of decahydroisoquinolines such as LY293558 with variable activity at AMPA receptors that are also capable of selectively blocking GluR5 kainate receptors (Ornstein et al., 1993; Bleakman et al., 1996; Clarke et al., 1997; Simmons et al., 1998), have made it possible to discriminate pharma…”
High‐affinity kainate‐type ion channels in rat cerebellar granule cells
Pemberton, K. E., Belcher, S. M., Ripellino, J. A., & Howe, J. R. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.401bk.x · Cited by 56
“Recent evidence supports the involvement of kainate-type channels in synaptic transmission in the hippocampus (Castillo, Malenka & Nicoll, 1997; Clarke et al. 1997; Rodriguez-Moreno, Herreras & Lerma, 1997; Vignes & Collingridge, 1997).”
BackgroundMaingret, F., Lauri, S. E., Taira, T., & Isaac, J. T. R. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.089474 · Cited by 55
“…receptor activation can regulate GABAergic transmission in neonatal rat hippocampus we bath applied the GluR5 selective kainate receptor agonist (RS)-2-amino-3-(3-hydroxy)-5-tert-butylisoxazol-4-yl) propanoic acid (ATPA) (Clarke et al. 1997; Cossart et al. 1998; Rodriguez-Moreno et al. 2000).”
BackgroundMethodResultInfluentialSun, H. Y., Bartley, A. F., & Dobrunz, L. E. (2009) · Journal of Neurophysiology · doi:10.1152/jn.90286.2008 · Cited by 55
“This most likely reflects the block of postsynaptic kainate receptors because postsynaptic kainate receptors containing GluR5 have been found on some CA1 interneurons (Clarke et al. 1997; Cossart et al. 1998; Mulle et al. 2000).”
NMDA Receptor-Mediated Control of Presynaptic Calcium and Neurotransmitter Release
Cochilla, A. J., & Alford, S. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00193.1999 · Cited by 55
“…that ionotropic glutamate receptors are present in mammalian presynaptic terminals (Agrawal and Evans, 1986; Barnes et al., 1994; Farb et al., 1995; Smirnova et al., 1993; Berretta and Jones, 1996; Dev et al., 1996; Aoki et al., 1997; Clarke et al., 1997; Conti et al., 1997; Liu et al., 1997).”
BackgroundSynthesis and Pharmacology of Willardiine Derivatives Acting as Antagonists of Kainate Receptors
Dolman, N. P., Troop, H. M., More, J. C. A., Alt, A. J., Knauss, J. L., Nisticò, R., Jack, S., Morley, R. M., Bortolotto, Z. A., Roberts, P., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050584l · Cited by 57
Self-citationKainate receptors: from synaptic activity to disease
Negrete‐Díaz, J. V., Falcón‐Moya, R., & Moreno, A. R. (2021) · FEBS Journal · doi:10.1111/febs.16081 · Cited by 62
Dolman, N. P., More, J. C. A., Alt, A., Knauss, J. L., Troop, H. M., Bleakman, D., Collingridge, G. L., & Jane, D. E. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051086f · Cited by 53
Self-citationAcute Effects of Ethanol on Kainate Receptors in Cultured Hippocampal Neurons
Costa, E. T., Soto, E. E., Cardoso, R. A., Olivera, D. S., & Valenzuela, C. F. (2000) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200002000-00013 · Cited by 53
Role of GluK1 Kainate Receptors in Seizures, Epileptic Discharges, and Epileptogenesis
Fritsch, B., Reis, J., Ga̧sior, M., Kaminski, R. M., & Rogawski, M. A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5307-13.2014 · Cited by 60
Subtype selective kainic acid receptor agonists: Discovery and approaches to rational design
Bunch, L., & Krogsgaard‐Larsen, P. (2008) · Medicinal Research Reviews · doi:10.1002/med.20133 · Cited by 52
“However, in 1997 ATPA was shown to be a selective, high affinity ligand at homomeric iGluR5 receptors (Table IX).(134) Furthermore, ATPAwas shown to be a full agonist at this KA receptor subtype (Table X).”
Kayadjanian, N., Lee, H. S., Piña-Crespo, J., & Heinemann, S. F. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.11.001 · Cited by 58
“…(Frerking and Nicoll, 2000), particularly for the GluR5 subunits because of the lack of pharmacological agents and specific antibodies (Clarke et al., 1997; Corresponding author: Nathalie Kayadjanian, Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies, La…”
BackgroundKainate receptors and the induction of mossy fibre long-term potentiation
Bortolotto, Z. A., Lauri, S. E., Isaac, J. T. R., & Collingridge, G. L. (2003) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2002.1216 · Cited by 59
“The most widely used selective agonist is 2-amino-3-(3hydroxy-5-tert-butylisoxazol-4-yl)propanoic acid (Clarke et al. 1997), which is very potent at GLUK 5 receptors and only affects AMPA receptors and other kainate receptors in considerably higher concentrations.”
BackgroundMethodSelf-citationLöscher, W., Lehmann, H., Behl, B., Seemann, D., Teschendorf, H. J., Hofmann, H. P., Lubisch, W., Höger, T., Lemaire, H.-G., & Groß, G. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00432.x · Cited by 51
Dargan, S. L., Clarke, V. R. J., Alushin, G. M., Sherwood, J. L., Nisticò, R., Bortolotto, Z. A., Ogden, A. M., Bleakman, D., Doherty, A. J., Lodge, D., et al. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.016 · Cited by 50
“We then went on to show that ACET is an effective antagonist of native GluK1-containing KARs in vitro at nanomolar concentrations: 200 nM ACET completely blocked ATPA-mediated depressions of both evoked fEPSPs (Vignes et al., 1998; Clarke and Collingridge, 2002) and IPSPs (Clarke et al.,1997; Clarke and Collingridge,…”
BackgroundInfluentialSelf-citationValgeirsson, J., Nielsen, E. Ø., Peters, D., Mathiesen, C., Kristensen, A. S., & Madsen, U. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030638w · Cited by 50
Altered Hippocampal Kainate-Receptor mRNA Levels in Temporal Lobe Epilepsy Patients
Mathern, G. W., Pretorius, J. K., Kornblum, H. I., Mendoza, D., Lozada, A., Leite, J. P., Chimelli, L., Born, D. E., Fried, I., Sakamoto, A. C., et al. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0200 · Cited by 50
PKC‐dependent autoregulation of membrane kainate receptors
Rivera, R., Rozas, J. L., & Lerma, J. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601865 · Cited by 57
Glutamate receptor functions in sensory relay in the thalamus
Salt, T. E. (2002) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2002.1165 · Cited by 49
Kainate Receptors and Pain: From Dorsal Root Ganglion to the Anterior Cingulate Cortex
Wu, L.-J., Ko, S., & Zhuo, M. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780765864 · Cited by 49
“In addition to a postsynaptic location, KA receptors also target to presynaptic terminals, where they regulate either excitatory or inhibitory neurotransmitter release [34, 35].”
BackgroundMalva, J. O., Silva, A. P., & Cunha, R. A. (2003) · Neurochemical Research · doi:10.1023/a:1025618324593 · Cited by 55
Chapter 32 Diadenosine polyphosphates, extracellular function and catabolism
Miras‐Portugal, M. T., Gualix, J., Mateo, J., Dı́az-Hernández, M., Gómez‐Villafuertes, R., Castro, E., & Pintor, J. J. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)63572-4 · Cited by 49
Ali, A. B. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02677.x · Cited by 48
Youn, D., & Randić, M. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.057570 · Cited by 51
“Based on the selectivity of ATPA for the GluR5 subunit (Clarke et al. 1997; Hoo et al. 1999), this effect was postulated to arise from the activation of presynaptic GluR5-KARs because the GluR5 subunit is expressed at a high level only on small-diameter DRG neurones (giving rise to C fibres), but…”
BackgroundChimirri, A., Gitto, R., & Zappalà, M. (1999) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.9.5.557 · Cited by 52
Kainate Receptors Coupled to Gi/GoProteins in the Rat Hippocampus
Cunha, R. A., Malva, J. O., & Ribeiro, J. A. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.2.429 · Cited by 52
“, 1998) or for the hyperpolarization of CA1 neurons caused by a kainate receptor (GLuR5) agonist (Clarke et al., 1997), with both effects being difficult to reconciliate with the activation of ionotropic receptors permeable to cations.”
Presynaptic kainate receptor-mediated bidirectional modulatory actions: Mechanisms
Sihra, T. S., & Moreno, A. R. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.03.012 · Cited by 52
“Thus, pioneering reports with GABAergic synapses in the hippocampus described KAR-mediat ed decrease of GABA release (RodríguezMoreno et al., 1997; Clarke et al., 1997 ), with pursuant reports then also describing a facilitation of GABA release (Cossart et al., 2001 ), this dichotomy likely…”
A Review of Glutamate Receptors I: Current Understanding of Their Biology
Rousseaux, C. G. (2008) · Journal of Toxicologic Pathology · doi:10.1293/tox.21.25 · Cited by 56
Role of kainate receptors in nociception
Ruscheweyh, R., & Sandkühler, J. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00203-5 · Cited by 47
Xu, J., Liu, Y. U., & Zhang, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800393200 · Cited by 49
Wyeth, M. S., Pelkey, K. A., Yuan, X., Vargish, G., Johnston, A. D., Hunt, S., Fang, C., Abebe, D., Mahadevan, V., Fisahn, A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.017 · Cited by 46
“In addition, KARs on GABAergic terminals, particularly those of CCK/CB1-expressing interneurons, regulate presynaptic release (Christensen et al., 2004; Clarke et al., 1997; Daw et al., 2010; Lourenço et al., 2010; Mulle et al., 2000; Rodrı́guez-Moreno et al., 1997).”
LY339434, a GluR5 kainate receptor agonist
Small, B. G., Thomas, J. W., Kemp, M., Hoo, K. H., Ballyk, B. A., Deverill, M., Ogden, A. M. L., Rubio, A., Pedregal, C., & Bleakman, D. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00122-1 · Cited by 50
Self-citationThe induction of N -methyl-D-aspartate receptor-dependent long-term potentiation
Collingridge, G. L. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2002.1241 · Cited by 46
Self-citationGhetti, A., & Heinemann, S. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02766.2000 · Cited by 46
“A presynaptic functional role of kainate receptors has also been reported in the CA1 region of the hippocampus, where activation of these receptors resulted in a decrease of GABA release (Clarke et al., 1997; Rodriguez-Moreno et al., 1997).”
BackgroundFerreri, G., Chimirri, A., Russo, E., Gitto, R., Gareri, P., Sarro, A. D., & Sarro, G. D. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.09.019 · Cited by 45
Vesikansa, A., Sallert, M., Taira, T., & Lauri, S. E. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.133975 · Cited by 50
“Another indirect mechanism that might mediate the effect of ATPA on glutamatergic connectivity is altered GABAergic drive due to activation of GluR5 subunit-containing KARs at CA1 interneurons (e.g. Clarke et al. 1997; Christensen et al. 2004; Maingret et al. 2005).”
BackgroundInfluentialPalma, E., Esposito, V., Mileo, A. M., Gennaro, G. D., Quarato, P. P., Giangaspero, F., Scoppetta, C., Onorati, P., Trettel, F., Miledi, R., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232574499 · Cited by 45
Pre- and postsynaptic effects of kainate on layer II/III pyramidal cells in rat neocortex
Campbell, S. L., Mathew, S. S., & Hablitz, J. J. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.04.008 · Cited by 49
“(RS)-2-amino-3(3-hydroxy-5-tert-butyl-isoxazol-4-yl) proprionic acid (ATPA), at low concentrations, is a selective GluR5 agonist (Clarke et al., 1997) and the GluR5 subunit is selectively blocked by (3S, 4aR, 6S, 8aR)-6-(4-carboxyphenyl)methyl-1,2,3,4,4a,5,6,7,8,8adecahydroisoquinoline-3-carboxylic…”
BackgroundClarke, V. R. J., & Collingridge, G. L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00039-4 · Cited by 49
Self-citationDaw, M. I., Pelkey, K. A., Chittajallu, R., & McBain, C. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6334-09.2010 · Cited by 43
“In a number of systems presynaptic actions of KAR activation have been ascribed to GluK1(formerly GluR5)-containing receptors (Clarke et al., 1997; Vignes et al., 1998; Fisahn et unitary IPSC (uIPSC) amplitude was measured (sIPSC frequency 6 –10 min after 1 M KA application 126 13% baseline, p 0.3,…”
BackgroundInfluentialKainate Receptors and Mossy Fiber LTP
Bortolotto, Z. A., Nisticò, R., More, J. C. A., Jane, D. E., & Collingridge, G. L. (2005) · NeuroToxicology · doi:10.1016/j.neuro.2005.02.004 · Cited by 49
Self-citation2,3-Benzodiazepine AMPA Antagonists
Tarnawa, I., & Vize, E. S. (1998) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-1998-00057 · Cited by 45
“This observation – together with the discovery of more specific kainate agonists [143] – gave a great impetus to the clarification of the physiological role of specific kainate receptors, especially in the hippocampus [15,24,27,31,81,177, 178,196].”
Pharmacological characterization of a GluR6 kainate receptor in cultured hippocampal neurons
Bleakman, D., Ogden, A.-M., Ornstein, P. L., & Hoo, K. H. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00478-1 · Cited by 43
Self-citationKainate receptor trafficking: physiological roles and molecular mechanisms
Isaac, J. T. R., Mellor, J. R., Hurtado, D. E., & Roche, K. W. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.006 · Cited by 47
Parallel Synthesis of Novel Heteroaromatic Acromelic Acid Analogues from Kainic Acid
Baldwin, J. E., Fryer, A. M., & Pritchard, G. J. (2001) · The Journal of Organic Chemistry · doi:10.1021/jo000846l · Cited by 42
Kainate Receptor Signaling in Pain Pathways
Bhangoo, S. K., & Swanson, G. T. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.081398 · Cited by 46
“neuronal KARs with similar potencies and gating properties (Wong et al., 1994; Clarke et al., 1997; Swanson et al., 1998; Kerchner et al., 2001b; Wilding and Huettner, 2001).”
BackgroundCharacterization of a domoic acid binding site from Pacific razor clam
Trainer, V. L., & Bill, B. D. (2004) · Aquatic Toxicology · doi:10.1016/j.aquatox.2004.04.012 · Cited by 44
“On the other hand, ATPA has low affinity for AMPA receptors due to its selectivity for GluR5 receptors of the KA receptor subgroup (Clarke et al., 1997).”
BackgroundMultireceptor GABAergic regulation of synaptic communication in amphibian retina
Shen, W., & Slaughter, M. M. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0055m.x · Cited by 42
“ATPA was chosen because it is a selective kainate receptor agonist (Clarke et al. 1997).”
Non-canonical mechanisms of presynaptic kainate receptors controlling glutamate release
Negrete-Díaz, J. V., Sihra, T. S., Flores, G., & Rodríguez-Moreno, A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00128 · Cited by 41
“Originally, it was ground-breaking work with hippocampal GABAergic synapses that espoused a KAR-mediated suppression of GABA release (Clarke et al., 1997; Rodríguez-Moreno et al., 1997), but subsequent investigations revealed that a facilitation of GABA release mediated by KARs could also be observed (Cossart et al.”
BackgroundIbrahim, H. M., Healy, D. J., Hogg, A. J., & Meador‐Woodruff, J. H. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00072-3 · Cited by 42
Functional diversity and developmental changes in rat neuronal kainate receptors
Wilding, T. J., & Huettner, J. E. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0411f.x · Cited by 47
“Recordings from transfected HEK cells have shown that ATPA activates current through homomeric channels formed by GluR5 (Clarke et al. 1997), as well as heteromeric receptors that include a GluR5 subunit (Cui & Mayer, 1999; Paternain et al. 2000).”
BackgroundMethodResultInfluentialKainate acts at presynaptic receptors to increase GABA release from hypothalamic neurons
Liu, Q.-S., Patrylo, P. R., Gao, X.-B., & van den Pol, A. N. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.2.1059 · Cited by 40
“Previous reports found a decrease in transmitter release with kainate activation of presynaptic receptors in hippocampal neurons in slice and culture (Clarke et al. 1997; RodriguezMoreno et al. 1997), whereas we find an increase in GABA release with kainate activation of hypothalamic neurons.”
BackgroundSallert, M., Malkki, H. A. I., Segerstråle, M., Taira, T., & Lauri, S. E. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.01.015 · Cited by 38
Glia-Dependent Switch of Kainate Receptor Presynaptic Action
Bonfardin, V. D. J., Fossat, P., Theodosis, D. T., & Oliet, S. H. R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3389-09.2010 · Cited by 43
“To identify the KAR subtype(s) involved in this effect, we applied the GluK1-containing KARs selective agonist ATPA (3 M) (Clarke et al., 1997; Bortolotto et al., 1999).”
Method
Metadata
- Authors
- Clarke, V. R. J., Ballyk, B. A., Hoo, K. H., Mandelzys, A., Pellizzari, A., Bath, C. P., Thomas, J., Sharpe, E. F., Davies, C. H., Ornstein, P. L., Schoepp, D. D., Kamboj, R. K., Collingridge, G. L., Lodge, D., & Bleakman, D.
- Affiliations
- University of Bristol (GB)
- Eli Lilly (United Kingdom) (GB)
- University of Edinburgh (GB)
- Eli Lilly (United States) (US)
- Venue
- Nature
- Published
- 1997-10
- Volume
- 389
- Issue
- 6651
- Pages
- 599-603
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1637705010
- Cited by
- 416
- References
- 32
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 6 · 2017: 7 · 2016: 7 · 2015: 4 · 2014: 7 · 2013: 5 · 2012: 11
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Wellcome Trust
- Chinese Academy of Agricultural Sciences
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- GluR5, kainate receptors, hippocampus, synaptic inhibition, atpA, glutamate receptors, epilepsy
- MeSH terms
- Animals, Cell Line, Cloning, Molecular, Hippocampus, Humans, Isoquinolines, Isoxazoles, Kainic Acid, Neural Inhibition, Propionates, Receptors, GABA-A, Synapses, Tetrazoles, Kainic Acid Receptors, Excitatory Amino Acid Agonists, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.